内容摘要："The political branches, not courts, make foreign policy and chart economic policy," it said in the filing.

"The political branches, not courts, make foreign policy and chart economic policy," it said in the filing.

A drug which has been proven to extend the life of some people with incurable breast cancer has been given to patients on the NHS in Wales for the first time.Gwen Buchan, 62, who has terminal breast cancer, said capivasertib would allow her to see her son's wedding and gave her "hope".

Half of women with breast cancer fuelled by the hormone oestrogen are likely to see their life expectancy double when capivasertib is combined with hormone therapy, research has shown.Prof Rob Jones, who co-led a study looking at capivasertib's effectiveness, said the drug offered "a real life impact for people to spend extra time with their relatives, with their friends".Breast cancer is the most common cancer in the UK, with one in seven women affected in their lifetimes and 75% surviving for 10 years or more after diagnosis.

In Wales, more than 2,000 people are diagnosed with breast cancer every year.Capivasertib, which was developed by experts at Velindre Cancer Centre and Cardiff University, became available to breast cancer patients on the NHS in April.

When Ms Buchan's first line of treatment for her terminal breast cancer stopped working, it was a set-back.

However, the recent approval of capivasertib for use on the NHS alongside hormone therapy will allow her to enjoy more time with family and friends.and Agincourt is under construction.

The next generation of attack submarines that will replace them, SSN-AUKUS, have been developed with the Australian Navy under aby the Conservative government.

Meanwhile work on modernising the warheads carried by Trident Missiles is already under way.The £15bn investment into the warhead programme will back the government's commitments to maintain the continuous-at-sea nuclear deterrent.